Literature DB >> 10770507

Transient visual loss after licorice ingestion.

K R Dobbins1, R F Saul.   

Abstract

The authors present a spectrum of clinical presentations of transient visual loss/aberrations and show that these occurrences were attributable to ingestion of significant amounts of licorice. A case series of five patients was seen at Geisinger Medical Center between October 1986 and May 1996. Details of patient presentation, treatment, and outcome are discussed. The literature on the effects of licorice derivatives on vascular smooth muscle function is reviewed. Of the five patients, two had documented visual loss by visual acuity testing and visual fields. All patients reported a recent ingestion of significant amounts of licorice (1/4-2 lbs.). All patients had resolution of their visual symptoms; the aid of hyperbaric oxygen was required for one patient. Thorough review of the literature shows recent in vitro and in vivo evidence of glycyrrhetinic acid (the active component of licorice) and carbenoxolone (the hemisuccinate derivative of glycyrrhetinic acid) directly and indirectly enhancing vasoconstrictor action in vascular smooth muscle. It is believed that licorice derivatives can cause retinal or occipital vasospasm, giving rise to transient monocular or binocular visual loss/aberrations. This has not been described before in the literature. It is important to ask about licorice ingestion with patients who present with these visual symptoms.

Entities:  

Mesh:

Year:  2000        PMID: 10770507     DOI: 10.1097/00041327-200020010-00013

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  9 in total

1.  Licorice-associated reversible cerebral vasoconstriction with PRES.

Authors:  N Chatterjee; K Domoto-Reilly; P E Fecci; L H Schwamm; A B Singhal
Journal:  Neurology       Date:  2010-11-23       Impact factor: 9.910

Review 2.  Ocular adverse effects associated with systemic medications : recognition and management.

Authors:  Ricardo M Santaella; Frederick W Fraunfelder
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Licorice abuse: time to send a warning message.

Authors:  Hesham R Omar; Irina Komarova; Mohamed El-Ghonemi; Ahmed Fathy; Rania Rashad; Hany D Abdelmalak; Muralidhar Reddy Yerramadha; Yaseen Ali; Engy Helal; Enrico M Camporesi
Journal:  Ther Adv Endocrinol Metab       Date:  2012-08       Impact factor: 3.565

Review 4.  Ophthalmologic migraine.

Authors:  Robert F Saul
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

5.  Transient Vision Loss.

Authors:  Carolyn Glazer-Hockstein; Nicholas J. Volpe
Journal:  Curr Treat Options Neurol       Date:  2004-01       Impact factor: 3.598

Review 6.  Glycyrrhiza glabra (Licorice): A Comprehensive Review on Its Phytochemistry, Biological Activities, Clinical Evidence and Toxicology.

Authors:  Shadma Wahab; Sivakumar Annadurai; Shahabe Saquib Abullais; Gotam Das; Wasim Ahmad; Md Faruque Ahmad; Geetha Kandasamy; Rajalakshimi Vasudevan; Md Sajid Ali; Mohd Amir
Journal:  Plants (Basel)       Date:  2021-12-14

7.  Anticonvulsant, sedative and muscle relaxant effects of carbenoxolone in mice.

Authors:  Hossein Hosseinzadeh; Marjan Nassiri Asl
Journal:  BMC Pharmacol       Date:  2003-04-29

Review 8.  Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds.

Authors:  Marjan Nassiri Asl; Hossein Hosseinzadeh
Journal:  Phytother Res       Date:  2008-06       Impact factor: 5.878

Review 9.  Glycyrrhiza Genus: Enlightening Phytochemical Components for Pharmacological and Health-Promoting Abilities.

Authors:  Javad Sharifi-Rad; Cristina Quispe; Jesús Herrera-Bravo; Lisandra Herrera Belén; Rajandeep Kaur; Dorota Kregiel; Yadav Uprety; Ahmet Beyatli; Balakyz Yeskaliyeva; Celale Kırkın; Beraat Özçelik; Surjit Sen; Krishnendu Acharya; Farukh Sharopov; Natália Cruz-Martins; Manoj Kumar; Ahmad Faizal Abdull Razis; Usman Sunusi; Ramla Muhammad Kamal; Shabnum Shaheen; Hafiz Ansar Rasul Suleria
Journal:  Oxid Med Cell Longev       Date:  2021-07-24       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.